Chronic kidney disease (CKD) affects millions of people globally and, for most patients, the
risk of developing cardiovascular disease is higher than that of progression to kidney failure …

This paper is the third in a series of reviews published in this issue resulting from the
University of California Davis Cardiovascular Symposium 2014: Systems approach to …

Uremic cardiomyopathy is responsible for high morbidity and mortality rates among patients
with chronic kidney disease (CKD) or end‐stage renal disease (ESRD); however, the early …

Chronic kidney disease (CKD) is a public health problem and a recognized risk factor for
cardiovascular diseases (CVD). CKD could amplify the progression of chronic heart failure …

Chronic kidney disease is highly prevalent, affecting 10% to 15% of the adult population
worldwide and is associated with increased cardiovascular morbidity and mortality. As …

Uremic cardiomyopathy is a classic complication of chronic renal failure whose cause is
unclear and treatment remains disappointing. Insulin resistance is an independent predictor …

Uremic cardiomyopathy is characterized by diastolic dysfunction (DD), left ventricular
hypertrophy (LVH), and fibrosis. Angiotensin-II plays a major role in the development of …

Background: Left ventricular (LV) hypertrophy (LVH) is present in more than 70% of patients
with kidney failure. Hypertension and anemia, 2 strong risk factors for LVH, are common in …

Chronic kidney disease (CKD) is a public health problem that increases the risk of
cardiovascular morbidity and mortality. Heart failure with preserved ejection fraction (HFpEF) …

Cardiomyopathies (CMs) have many etiological factors that can result in severe structural
and functional dysregulation. Fortunately, there are several potentially reversible CMs that …